# Robin Condliffe

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robin-condliffe/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,364 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 67 |
| i10-index | 150 |
| Last Known Institution | Royal Hallamshire Hospital |
| OpenAlex ID | https://openalex.org/A5069317832 |
| ORCID iD | https://orcid.org/0000-0002-3492-4143 |
| Works | 367 |

## Researcher papers

- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era](https://scholariq.org/papers/connective-tissue-disease-associated-pulmonary-arterial-hypertension-in-the/)
- [Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension](https://scholariq.org/papers/improved-outcomes-in-medically-and-surgically-treated-chronic-thromboembolic/)
- [Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension](https://scholariq.org/papers/prognostic-and-aetiological-factors-in-chronic-thromboembolic-pulmonary/)
- [Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5/)
- [Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension](https://scholariq.org/papers/phenotypic-characterization-of-i-eif2ak4-i-mutation-carriers-in-a-large-cohort/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Researcher university

- [Royal Hallamshire Hospital](https://scholariq.org/institutions/royal-hallamshire-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.